KZIA

Conviction 66HealthcareScan · Mon, Aug 10, 2026

KZIA$14.09+1.48%

ResistanceSupportVol 14

Vol MA14 242.05K

May 11May 28Jun 16Jul 6Jul 23Aug 10

KAZIA THERAPEUTICS LTDPHARMACEUTICAL PREPARATIONSwww.kaziatherapeutics.com ↗

Price14.09

Change+1.48%

Gap-2.77%

Rel volume1.32×

Avg volume211.86K

Avg $ vol2.75M

SMA 2013.02

SMA 5013.07

SMA 2009.93

Price vs 50+7.83%

Price vs 200+41.84%

MA stackbullish

50/200 cross—

Supertrendup · 11.52

RSI (14)59

MACD hist0.11

MACD crossbull · 1d

Stoch %K / %D78 / 60

ADX (14)15

+DI / −DI26 / 16

RSI divergenceBullish

MACD divergenceBullish

ATR %+7.78%

ADR %8.14%

52w high15.72

52w low5.00

From 52w high-10.37%

Above 52w low+181.80%

New 52w highNo

SqueezeOn · 2d

Bollinger width23.15%

%B0.86

Donchian pos78.14%

Donchian high14.82

Donchian low11.48

AVWAP (52w high)10.19

vs AVWAP high+38.25%

AVWAP (52w low)11.20

vs AVWAP low+25.76%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d1.32×

Avg vol (14d)242.05K

Avg vol (20d)211.86K

Avg $ vol (20d)2.75M

Market cap11.4B

RS 3m (vs SPY)-2.16%

RS 6m (vs SPY)+132.95%

RS line new highNo

Trend template7/8

Technical rank87.6

1 week+13.54%

1 month+3.91%

3 months-2.42%

6 months+143.35%

1 year+71.00%

YTD+181.80%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value11.4B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out11.34M

Employees6

ListedWed, Jan 6, 1999

Free float—

Float %—

Short interest740.43K

Days to cover4.1d

Short volume44.1%

Squeeze score47 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction66 / 100

Pattern quality—

Tech rank87.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.28

Support11.53

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in KZIA

All disclosures →

No recent disclosed trades by Congress in KZIA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KZIA · 6 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
APPLE ROBERT F Director · Employee Stock Option (right to buy) · 2026-01-08	Grant	75K	—	2026-01-08	2026-07-08
Bonacorda Jeffrey VP, Finance and Controller · Employee Stock Option (right to buy) · 2026-01-08	Grant	150K	—	2026-01-08	2026-07-08
Cain David Director, CMC · Employee Stock Option (right to buy) · 2026-01-08	Grant	100K	—	2026-01-08	2026-07-08
Coffey Steven R. S. Director · Employee Stock Option (right to buy) · 2026-01-08	Grant	100K	—	2026-01-08	2026-07-08
Davidson Ebru Director · Employee Stock Option (right to buy) · 2026-01-08	Grant	100K	—	2026-01-08	2026-07-08
Friend John E. II Chief Executive Officer · Employee Stock Option (right to buy) · 2026-01-08	Grant	500K	—	2026-01-08	2026-07-08
Friend John E. II Chief Executive Officer · Restricted Share Units · 2026-01-08	Grant	150K	—	2026-01-08	2026-07-08

SEC filings

EDGAR filings in KZIA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.